By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Ventana Medical Systems and Syndax Pharmaceuticals have signed an agreement for the development of a companion diagnostic for a drug being developed by Syndax to treat non-small cell lung cancer patients.
Registering provides access to this and other free content.
Already have an account?Login Now.
In a series of articles, medical journals debate the necessity of conflict-of-interest policies.
Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.
In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.
With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.